SCHEMBL19946100

SCHEMBL19946100

CCn1c(=O)c2cc(O)c(Cl)cc2c2ccnc(C)c21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 8/20 0.57
▸ SRC P12931 2/20 0.45
▸ DYRK1A Q13627 9/20 0.44
▸ DAPK3 O43293 1/20 0.41
▸ MET P08581 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ KDR P35968 1/20 0.41
▸ CSNK1D P48730 1/20 0.41
▸ GSK3A P49840 1/20 0.41
▸ RPS6KA3 P51812 1/20 0.41
▸ CSNK2A1 P68400 1/20 0.41
▸ PRKAA1 Q13131 1/20 0.41
▸ PAK1 Q13153 1/20 0.41
▸ STK3 Q13188 1/20 0.41
▸ PIM2 Q9P1W9 1/20 0.41
▸ PRKAB1 Q9Y478 1/20 0.41
▸ PRKACA P17612 1/20 0.38
▸ PRKACG P22612 1/20 0.38
▸ PRKACB P22694 1/20 0.38
▸ HASPIN Q8TF76 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19946082 0.84 AAK1 (0.56) AAK1DYRK1AHASPINDYRK2
SCHEMBL19946055 0.83 AAK1 (0.66) AAK1DYRK1APIM1HASPINDYRK2
SCHEMBL19946130 0.81 AAK1 (0.55) AAK1DYRK1A
SCHEMBL19946156 0.81 AAK1 (0.58) AAK1DYRK1A
SCHEMBL19946062 0.79 SRC (0.40) AAK1SRCDYRK1ADAPK3MET
SCHEMBL21019093 0.75 AAK1 (0.66) AAK1DYRK1AHASPINDYRK2
SCHEMBL20164851 0.74 AAK1 (1.00) AAK1
SCHEMBL20164850 0.74 AAK1 (1.00) AAK1
SCHEMBL19946128 0.72 AAK1 (0.84) AAK1
SCHEMBL20181301 0.72 AAK1 (0.74) AAK1DYRK1AHASPINDYRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3292124-B1 6H-ISOCHROMENO[3,4-C]PYRIDINES AND BENZO[C][1,7]NAPHTHYRIDIN-6-(5H)-ONES AS ADAPTOR ASSOCIATED KINASE 1 (AAK1) INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2019-05-22 — — EP disclosed
EP-3292124-B1 6H-ISOCHROMENO[3,4-C]PYRIDINES AND BENZO[C][1,7]NAPHTHYRIDIN-6-(5H)-ONES AS ADAPTOR ASSOCIATED KINASE 1 (AAK1) INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2019-05-22 — — EP disclosed
US-10174044-B2 Fused pyridines as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2019-01-08 — — US disclosed
US-10174044-B2 Fused pyridines as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2019-01-08 — — US disclosed
US-20180141956-A1 FUSED PYRIDINES AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-24 — — US disclosed
US-20180141956-A1 FUSED PYRIDINES AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-24 — — US disclosed
US-20180141956-A1 FUSED PYRIDINES AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-24 — — US disclosed
EP-3292124-A2 FUSED PYRIDINES AS ADAPTOR ASSOCIATED KINASE 1 (AAK1) INHIBITORS Bristol-Myers Squibb Company (US) 2018-03-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10174044-B2 Fused pyridines as kinase inhibitors AAK1, NCK1, ADCK1 AAK1 1/4885SRC 171/4885DYRK1A 518/4885
US-20180141956-A1 FUSED PYRIDINES AS KINASE INHIBITORS AAK1, NCK1, ADCK1 AAK1 1/4885SRC 171/4885DYRK1A 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback